RMOC guidance

  • The Regional Medicines Optimisation Committee (RMOC) have clarified the guidance issued to Clinical Commissioning Groups (CCGs) on the prescribing of liothyronine. This updated guidance was published in July 2019 and can be found on this link. 


Switching your patient from liothyronine to levothyroxine

  • Most health authorities now advise GPs to switch patients on Liothyronine (L-T3) to Levothyroxine (L-T4). The British Thyroid Association has produced guidance for GPs in these circumstances.

Switching your patient from liothyronine to levothyroxine: answering GPs' frequently asked questions

When a trial of L-T3/L-T4 might be considered for treatment of hypothyroidism

(Video shared with kind permission from CoMICS bit.ly/SimbaComics)

We rely on donations to fund our work supporting and informing people living with thyroid disorders. Please consider making a donation or becoming a member


Become a member